AstraZeneca’s Enhertu (trastuzumab deruxtecan) emerged as the highest-selling new drug in India in 2024, generating Rs 58 ...

Benchmark NSE Nifty50 index was down 85.25 points at 22844.0, while the BSE Sensex was down 304.69 points at 75634.52. Among ...

US tariffs on pharmaceutical imports will affect Indias pharma sector, a leader in affordable generics. Analyst Vishal ...

Indian pharmaceutical and steel sectors show resilience against proposed US trade tariffs. Sun Pharma's Shanghvi indicates ...

GlaxoSmithKline Pharmaceuticals shares surged 20% to ₹2,421.30 after a strong Q3FY25 performance, reporting a 400% rise in ...

The revenue from operations at Glenmark Pharma during Q3FY25 also marked a 35.1 per cent year-on-year (YoY) rise to Rs ...

Piramal Pharma has awarded its integrated media mandate to OMD India, part of Omnicom Media Group. Following a multi-round ...

The company posted a multifold jump per cent in consolidated net profit to Rs 230 crore as compared to Rs 46 crore a year ago ...

Alembic Pharma: Alembic Pharmaceuticals Ltd announced that it received an Establishment Inspection Report (EIR) from the US FDA for its solid oral formulation facility (F-4) at Jarod, Vadodara. The ...

Stocks including Wirpo, BHEL, Shriram Finance, ABB India, Rail Vikas Nigam, Glenmark Pharma, ABFRL, Ircon and more will be in ...

As the market opens for a new trading day, here are some stocks that are in focus. From BHEL’s new contract to Glenmark ...

The NSE Nifty 50 ended 102.15 points, or 0.44% lower at 22,929.25, and the 30-stock BSE Sensex closed 199.76 points, or 0.26% ...